Follow The Filings

PLSE Pulse Biosciences

Pulse Biosciences earnings company data as of 5:02 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PLSE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PLSE insider trades
  • $13.5M bought by 3 insiders
  • None no sales outside a trading plan
  • $2.9M sold by 1 insider under 10b5-1 plans
  1. Liane Rae Teplitsky COO
    Buy
    $100K 2,025 shares at $49.37 +98% to stake
    Traded Aug 31–Sep 1 Filed Sep 2
    ↗
  2. Liane Rae Teplitsky COO
    Buy
    $100K 2,070 shares at $48.29 New stake
    Traded Aug 26–28 Filed Aug 28
    ↗
  3. Robert W Duggan Director
    Buy
    $13M 660,233 shares at $19.69 +1.4% to stake
    Traded May 11 Filed May 15
    ↗
  4. Paul A Laviolette CEO
    Buy
    $295K 15,000 shares at $19.69 +1773% to stake
    Traded May 11 Filed May 11
    ↗
  5. Kevin Patrick Danahy Chief Commercial Officer
    Planned sale
    $118K 5,000 shares at $23.64 10% of stake
    Traded Feb 18 Filed Feb 23
    ↗
  6. Kevin Patrick Danahy Chief Commercial Officer
    Planned sale
    $1.4M 60,000 shares at $23.51 58% of stake
    Traded Feb 12–17 Filed Feb 17
    ↗
  7. Kevin Patrick Danahy Chief Commercial Officer
    Planned sale
    $1.4M 60,000 shares at $23.39 58% of stake
    Traded Feb 9–11 Filed Feb 11
    ↗

Also filed in the last 12 months, not counted as buying or selling: 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 1.01,1.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
424B5 FORM 424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
DEF 14A FORM DEF 14A Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-K/A FORM 10-K/A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.